Bioethics

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

Today, the biotechnology industry is enjoying more success and influence than ever before. Our industry’s innovations continue to improve the lives of people worldwide, and the advancement of these innovations is supported by the work of BIO.

Read this compelling story to understand some of the bioethical concerns biotechnology companies face in the modern world.

What happens in Washington influences biotechnology progress every bit as much as what happens on Wall Street or in the lab.

HHS Addresses Many of BIO's Concerns In Proposing Changes to the HIPAA Privacy Regulation

"Some History Should be Repeated," by Carl B. Feldbaum, Science, Feb. 8, 2002. An excerpt appears below.

Biotechnology tools and techniques open new research avenues for discovering how healthy bodies work and what goes wrong when problems arise.

Position of the Biotechnology Industry Organization (BIO), regarding oversight of gene therapy

With the increasing computerization of medical records and the consolidation of the health care system, people have become more concerned about the potential threat to the confidentiality of individual health information.

Letters, Testimony & Comments

November 16 2011
Given by Russell M. Medford, MD, PhD President and CEO, Salutria Pharmaceuticals, LLC BIO Board Standing Committee on Bioethics Co-...
May 27 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
June 6 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
April 10 2007
Letter to Senate Majority Leader Henry Reid

Press Releases

November 17 2011
WASHINGTON, D.C. (Thursday, November 17, 2011) - Russell M. Medford, MD, PhD, President and CEO of Salutria...
December 16 2010
WASHINGTON, D.C. (Thursday, December 16, 2010) - Research and development in synthetic biology is an evolution of...
September 29 2010
WASHINGTON, D.C. (Wednesday, September 29, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
August 24 2010
WASHINGTON, D.C. (Tuesday, August 24, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
May 24 2010
WASHINGTON, D.C. (Monday, May 24, 2010) - Achievement of a milestone in creating synthetic life in the form of a...